|
|
||||||||
EDUCATION EXHIBIT |
1 From the Departments of Radiology (C.M.I., S.M.K.) and Medicine (S.J., J.L.M., E.P.M.), Thomas Jefferson University School of Medicine, 132 S 10th St, Philadelphia, PA 19107; the Department of Radiology, St Vincents Hospital, New York, NY (H.C.L.); and the Lankenau Institute for Medical Research, Wynnewood, Pa (D.M.C.). Received August 31, 2006; revision requested October 24 and received December 20; accepted January 15, 2007. All authors have no financial relationships to disclose. Address correspondence to C.M.I. (e-mail: charles.intenzo{at}jefferson.edu).
Radionuclide imaging is often used in the diagnosis and work-up of a wide range of neoplasms, on the basis of the biologic behavior of the tumor. Neuroendocrine tumors are a subgroup of neoplasms that are generally small and slow growing, and consequently their identification with conventional anatomic imaging can be difficult. Depending on the physiologic properties of the tumor, functional images obtained with radionuclides are often complementary to anatomic images, not only in the localization of the tumor and its metastases, but also in the assessment of prognosis and response to therapy. Familiarity with the choice of the appropriate radiopharmaceutical, proper imaging protocols, and the wide range of imaging patterns will enable the radiologist to guide the clinician in case management.
© RSNA, 2007
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOGRAPHICS | RADIOLOGY | RSNA JOURNALS ONLINE |